Security key
396879108
- Security type / class
- Equity / COM
- Total 13F shares
- 1,536
- Total 13F value
- $27,725
- Share change
- +178
- SEC-reported price per share
- $18.05
- Number of holders
- 2
- Value change
- +$3,213
- Number of buys
- 2
Report period
Q3 2026
Institutions
2
Top holders
2
GLSI full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
Greenwich LifeSciences, Inc. SEC filings
Greenwich LifeSciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 396879108
Recent filing periods:
Ownership snapshot
Top reported holders of GLSI - Greenwich LifeSciences, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Snehal Patel
Disclosed value leader
Snehal Patel
Comparable rows
0/15
Latest evidence
28 Jul 2026
3/4/5
13F
Highest disclosed value: $73,509,366
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Snehal Patel has the largest disclosed position value at $73.51M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Snehal Patel's linked filing trail.
Disclosed position value
Top 5
Snehal Patel
$73.51M
BlackRock, Inc.
$11.4M
VANGUARD CAPITAL MANAGEMENT LLC
$6.53M
GEODE CAPITAL MANAGEMENT, LLC
$3.95M
Jaye Thompson
$3.41M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Snehal Patel |
3/4/5
CEO and CFO, Director, 10%+ Owner
|
—
mixed-class rows
|
$73,509,366
7,958,864 shares
mixed-class rows
|
+$452,768 | 28 Jul 2026 |
| BlackRock, Inc. |
13F
Company
|
—
class O/S missing
|
$11,398,136
485,854 shares
|
— | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
class O/S missing
|
$6,526,337
278,190 shares
|
— | 30 Jun 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$3,946,578
168,179 shares
|
— | 30 Jun 2026 |
| Jaye Thompson |
3/4/5
VP Clinical Reg Affairs
|
—
mixed-class rows
|
$3,410,151
563,784 shares
mixed-class rows
|
— | 24 Dec 2024 |
| STATE STREET CORP |
13F
Company
|
—
class O/S missing
|
$3,356,798
143,086 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
1,536
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
57
Q3 2026 holders
2
Holder diff
-55
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend